In Vivo Discriminative Stimulus (CUE) Properties in Rats of Beta-Phenylethylamine

  • A. J. Goudie
  • D. Reid


In recent years the drug discrimination (DD) bioassay has proved of value in analysing drug actions (Colpaert and Slangen, 1982). This procedure is a whole animal assay for analysis in vivo of actions of drugs and endogenous agents, thus it may be useful in analysing functions of endogenous trace amines. Colpaert et al. (1980) suggested that the cue properties of cocaine in the DD procedure are mediated by PEA, since the potencies of MAO inhibitors in generalising to cocaine depended on their relative potencies in inhibiting MAO Type B, for which PEA is a preferred substrate. Huang and Ho (1974) reported that rats discriminating amphetamine generalized to PEA after pretreatment with iproniazid. These data suggest that the cue properties of stimulant drugs may be mediated by endogenous PEA. We have therefore been involved in recent years with:- (I) Analysis of the actions of PEA as a “training” drug and, (II) Analysing PEA’s actions in animals discriminating the stimulant dl-cathinone.


Drug Discrimination Generalization Test Stimulant Drug Partial Generalization Discriminative Stimulus Property 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Blake M.I., Crespi H.K. and Katz J.J. (1975) Studies with deuterated drugs. J. Pharmaceutical Sci. 64, 367-391.CrossRefGoogle Scholar
  2. Blau, K. (1978) The significance of phenylethylamine in phenylketonuria and related disorders. In: Noncatecholic Phenylethylamines. Part 1 (Mosnaim A.D. and Wolf M.E., eds.) pp. 385–396, Marcel Dekker, New York.Google Scholar
  3. Colpaert F.C., Niemegeers C.J.E. and Janssen P.A.J. (1980) Evidence that a preferred substrate for Type B monoamine oxidase mediates stimulus properties of MAO inhibitors: A possible role for B-phenylethylamine in the cocaine cue. Pharmacol. Biochem. Behav. 13, 513-517.PubMedCrossRefGoogle Scholar
  4. Colpaert F.C., Kuyps J.J.M.D., Niemegeers C.J.E. and Janssen P.A.J. (1976) Discriminative stimulus properties of a low dl-Amphetamine dose. Arch. int. Pharmacodyn. Therap. 223, 34–42.Google Scholar
  5. Colpaert F.C. and Janssen P.A.J. (1982) Factors regulating drug cue sensitivity: Limits of discriminability and the role of a progressively decreasing training dose in cocaine-saline discrimination. Neuropharmacology 21, 1187–1194.PubMedCrossRefGoogle Scholar
  6. Colpaert F.C. and Slangen J.L. (1982) Drug Discrimination: Applications in C.N.S. Pharmacology Elsevier Biomedical Press, Amsterdam.Google Scholar
  7. Colpaert F.C. and Janssen, P.A.J. (1984) Agonist and antagonist effects of prototype opiate drugs in rats discriminating fentamyl from saline: Characteristics of partial generalization. J. Pharmac. exp. Therap. 230, 193–199.Google Scholar
  8. Emmett-Oglesby M., Wurst M. and Lai H. (1983) Discriminative stimulus properties of a small dose of cocaine. Neuropharmacology 22, 97–101.PubMedCrossRefGoogle Scholar
  9. Goudie, A.J. (1977) Discriminative stimulus properties of fenfluramine in an operant task. Psychopharmacology 53, 97–102.PubMedCrossRefGoogle Scholar
  10. Goudie, A.J. (1982) Discriminative stimulus properties in an operant task of beta-phenylethylamine. In: Drug Discrimination: Applications in C.N.S. Pharmacology (Colpaert F.C. and Slangen J.L. eds.) pp. 165–180, Elsevier Biomedical Press, Amsterdam.Google Scholar
  11. Huang J.T. and Ho B.T. (1974) The effects of pretreatment with iproniazid on the behavioral activities of B-phenylethylamine in rat. Psychopharmacologia 35, 77-81.CrossRefGoogle Scholar
  12. Kalix P. (1984) The pharmacology of Khat. Gen. Pharmacol. 15, 179–187.PubMedGoogle Scholar
  13. Koek W. and Slangen J.L. (1984) External stimulus control in a “drug-discrimination” procedure: Drug effects and inter-animal variation. Psychopharmacology, 82, 168–173.PubMedCrossRefGoogle Scholar
  14. Sandler M. and Reynolds G.P. (1976) Does phenylethylamine cause schizophrenia? Lancet, 1, 70–71.PubMedCrossRefGoogle Scholar
  15. Shannon H.E. and De Gregorio C.M. (1982) Self-administration of the endogenous trace amines B-phenylethylamine, N-Methyl Phenylethylamine and Phenylethanolamine in dogs. J. Pharmac. exp Therap. 222, 52–60Google Scholar

Copyright information

© The Humana Press Inc. 1985

Authors and Affiliations

  • A. J. Goudie
    • 1
  • D. Reid
    • 1
  1. 1.Psychology DepartmentLiverpool UniversityLiverpoolEngland

Personalised recommendations